CPIX (Cumberland Pharmaceuticals Inc) Stock Analysis - Financials

Cumberland Pharmaceuticals Inc (CPIX) is a publicly traded Healthcare sector company. As of May 21, 2026, CPIX trades at $5.47 with a market cap of $76.71M and a P/E ratio of -11.37. CPIX moved +0.00% today. Year to date, CPIX is +38.25%; over the trailing twelve months it is +9.94%. Its 52-week range spans $1.04 to $7.25. Rallies surfaces CPIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CPIX's key financials?

CPIX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CPIX recently traded at $5.47. Market cap is $76.71M. P/E ratio is -11.37. Revenue is $41.94M.

CPIX Key Metrics

Key financial metrics for CPIX
MetricValue
Price$5.47
Market Cap$76.71M
P/E Ratio-11.37
EPS$-0.49
Dividend Yield0.00%
52-Week High$7.25
52-Week Low$1.04
Volume1.63K
Avg Volume0
Revenue (TTM)$41.94M
Net Income$-7.40M
Gross Margin82.89%

CPIX Annual Financials

YearRevenueNet IncomeEPS
2025$44.52M$-2.86M$-0.19
2024$37.87M$-6.44M$-0.46
2023$39.55M$-6.33M$-0.44
2022$42.01M$-5.65M$-0.38

Latest CPIX News

Recent CPIX Insider Trades

  • Young Caroline bought 6 (~$20.7) on Aug 29, 2025.
  • Jones James bought 13 (~$44.85) on Aug 29, 2025.
  • KAZIMI A J bought 13 (~$44.85) on Aug 29, 2025.

CPIX Analyst Consensus

CPIX analyst coverage data. Average price target: $0.00.

Common questions about CPIX

What are CPIX's key financials?
CPIX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CPIX recently traded at $5.47. Market cap is $76.71M. P/E ratio is -11.37. Revenue is $41.94M.
Is CPIX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CPIX. It does not provide personalized investment advice.
CPIX

CPIX